US FDA approves Covid booster shot for people above 65

The US Food and Drug Administration (USFDA) has authorised booster shots of the Pfizer Covid-19 vaccine for people aged 65 and older or at high-risk, according to the US official statement.

In a statement late Wednesday, Acting FDA Commissioner Janet Woodcock said: "After considering the totality of the available scientific evidence and the deliberations of our advisory committee of independent, external experts, the Food and Drug Administration amended the emergency use authorization for the Pfizer-BioNTech Covid-19 vaccine to allow for a booster dose in certain populations such as health care workers, teachers and day care staff, grocery workers and those in homeless shelters or prisons, among others.

The FDA said boosters were also authorised for people between the ages of 18 through 64 who are at high risk, as well as those "whose frequent institutional or occupational exposure" to the virus puts them at high risk of serious complications from the disease, according to reports by Xinhua news.

The FDA Commissioner said -"This pandemic is dynamic and evolving, with new data about vaccine safety and effectiveness becoming available every day. "As we learn more about the safety and effectiveness of COVID-19 vaccines, including the use of a booster dose, we will continue to evaluate the rapidly changing science and keep the public informed."  

The FDA added that booster doses are to be administered at least six months after the completion of the second shot.

Covid Roundup: India records 31,923 new COVID cases, active cases decline to 3.01 lakh

We request PM to postpone the idea of ​​exporting vaccines: Minister of Health and Family Welfare

Britain finally agreed, gave approval to Indian vaccine Covishield, travel advisory issued


- Sponsored Advert -

Most Popular

- Sponsored Advert -